Fact CheckerSign in

NCT07050875Completed

Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting

Source: ClinicalTrials.gov · Last updated 27 Jan 2026

Brief summary (registry, in English)

The primary objective of the study is to validate the safety and clinical performance of the ABLE Exoskeleton device in people with acquired brain injury during a 10-session gait training program in a clinical setting. The secondary objective of the study focuses on obtaining preliminary data on the potential clinical and psychosocial benefits of the product.

Status (registry)
Completed
Study type
Interventional
Enrollment
14 (actual)
First submitted
16 Jun 2025
Start date
30 Jun 2025
Primary completion date
17 Dec 2025
Lead sponsor
ABLE Human Motion S.L.
Diseases
Stroke
NCT number
NCT07050875

What you commit to

  • Study type: Interventional
  • Participants enrolled: 14
  • From 30 Jun 2025 to the primary completion date, 17 Dec 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unresolved fractures in the pelvis or extremities, or history of fragility fractures in the lower extremities in the last 2 years
  • Unstable cardiovascular system (CVS), hemodynamic instability, untreated hypertension (SBP\>140, DBP\>90 mmHg), unresolved deep venous thrombosis (DVT), uncontrolled autonomic dysreflexia
  • Serious comorbidities, including any condition that a physician deems inappropriate for use of the ABLE Exoskeleton or to complete participation in the study
  • Grade I or higher on EPUAP (European Pressure Ulcer Advisory Panel, 2019) on areas that will be in contact with the exoskeleton
  • Cognitive impairment that results in the inability to follow simple instructions, particularly psychological or cognitive problems that do not allow a participant to follow study procedures

Other

  • Significant osteoporosis that may increase the risk of fracture
  • Spinal instability (or spinal orthoses, unless authorized by a physician)
  • Severe spasticity: Level 4 on the Modified Ashworth Scale
  • Orthostatic hypotension. Inability to tolerate a minimum of 10 minutes standing
  • Uncontrolled autonomic dysreflexia
  • Medical instability
  • Skin integrity problems on the contact surfaces of the device or that would prevent sitting
  • Colostomy
  • Anthropometric measurements outside the values compatible with ABLE Exoskeleton. In particular, height not between 1.5-1.9 m, or weight over 100 kg
  • Anatomical constraints (such as leg length differences, users unable to position themselves inside the device) that are incompatible with the device
  • Restrictions in range of motion that prevent normal gait from being achieved or preventing the completion of a normal transition from sitting to standing or standing to sitting
  • Heterotopic ossification
  • Known pregnancy or breastfeeding
  • Requires assisted ventilation.
  • Scoliosis \>40-50º Cobb angle.

Who the study is looking for

  • 18 to 80 years old
  • Diagnosed with acquired brain injury (ABI)
  • Currently undergoing outpatient physical therapy treatment in one of the investigation sites
  • Ability to give informed consent

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cefine Neurología (CEFINE)
Coordinator of this site? Confirm its status
CulleredoSpainUnknown status
Fundación Step by Step
Coordinator of this site? Confirm its status
L'Hospitalet de LlobregatSpainUnknown status
Centro Europeo de Neurociencias (CEN)
Coordinator of this site? Confirm its status
MadridSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.